<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">46924</article-id><article-id pub-id-type="doi">10.7554/eLife.46924</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Structure based inhibitors of Amyloid Beta core suggest a common interface with Tau</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-62473"><name><surname>Griner</surname><given-names>Sarah L</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-135899"><name><surname>Seidler</surname><given-names>Paul</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-135900"><name><surname>Bowler</surname><given-names>Jeannette</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-111993"><name><surname>Murray</surname><given-names>Kevin A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-135901"><name><surname>Yang</surname><given-names>Tianxiao Peter</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4479-5154</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-111985"><name><surname>Sahay</surname><given-names>Shruti</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-41062"><name><surname>Sawaya</surname><given-names>Michael R</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-41061"><name><surname>Cascio</surname><given-names>Duilio</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-135902"><name><surname>Rodriguez</surname><given-names>Jose A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-73090"><name><surname>Philipp</surname><given-names>Stephan</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-135903"><name><surname>Sosna</surname><given-names>Justyna</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-31825"><name><surname>Glabe</surname><given-names>Charles G</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-122211"><name><surname>Gonen</surname><given-names>Tamir</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9254-4069</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-5056"><name><surname>Eisenberg</surname><given-names>David S</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2432-5419</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><institution>Howard Hughes Medical Institute, University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Molecular Biology and Biochemistry</institution>, <institution>University of California, Irvine</institution>, <addr-line><named-content content-type="city">Irvine</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution>Janelia Research Campus, Howard Hughes Medical Institute</institution>, <addr-line><named-content content-type="city">Ashburn</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1190"><name><surname>Sundquist</surname><given-names>Wesley I</given-names></name><role>Reviewing editor</role><aff><institution>University of Utah School of Medicine</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>sgriner@ucla.edu</email> (SG);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>david@mbi.ucla.edu</email> (DE);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>15</day><month>10</month><year>2019</year></pub-date><volume>8</volume><elocation-id>e46924</elocation-id><history><date date-type="received"><day>16</day><month>03</month><year>2019</year></date><date date-type="accepted"><day>04</day><month>10</month><year>2019</year></date></history><permissions><copyright-statement>© 2019, Griner et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Griner et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-46924-v1.pdf"/><abstract><p>Alzheimer's disease (AD) pathology is characterized by plaques of amyloid beta (Aβ) and neurofibrillary tangles of tau. Aβ aggregation is thought to occur at early stages of the disease, and ultimately gives way to the formation of tau tangles which track with cognitive decline in humans. Here, we report the crystal structure of an Aβ core segment determined by MicroED and in it, note characteristics of both fibrillar and oligomeric structure. Using this structure, we designed peptide-based inhibitors that reduce Aβ aggregation and toxicity of already-aggregated species. Unexpectedly, we also found that these inhibitors reduce the efficiency of Aβ-mediated tau aggregation, and moreover reduce aggregation and self-seeding of tau fibrils. The ability of these inhibitors to interfere with both Aβ and tau seeds suggests these fibrils share a common epitope, and supports the hypothesis that cross-seeding is one mechanism by which amyloid is linked to tau aggregation and could promote cognitive decline.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01 AG029430</award-id><principal-award-recipient><name><surname>Griner</surname><given-names>Sarah L</given-names></name><name><surname>Seidler</surname><given-names>Paul</given-names></name><name><surname>Bowler</surname><given-names>Jeannette</given-names></name><name><surname>Murray</surname><given-names>Kevin A</given-names></name><name><surname>Yang</surname><given-names>Tianxiao Peter</given-names></name><name><surname>Sahay</surname><given-names>Shruti</given-names></name><name><surname>Sawaya</surname><given-names>Michael R</given-names></name><name><surname>Cascio</surname><given-names>Duilio</given-names></name><name><surname>Rodriguez</surname><given-names>Jose A</given-names></name><name><surname>Eisenberg</surname><given-names>David S</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000011</institution-id><institution>Howard Hughes Medical Institute</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Griner</surname><given-names>Sarah L</given-names></name><name><surname>Seidler</surname><given-names>Paul</given-names></name><name><surname>Bowler</surname><given-names>Jeannette</given-names></name><name><surname>Murray</surname><given-names>Kevin A</given-names></name><name><surname>Yang</surname><given-names>Tianxiao Peter</given-names></name><name><surname>Sahay</surname><given-names>Shruti</given-names></name><name><surname>Sawaya</surname><given-names>Michael R</given-names></name><name><surname>Cascio</surname><given-names>Duilio</given-names></name><name><surname>Rodriguez</surname><given-names>Jose A</given-names></name><name><surname>Gonen</surname><given-names>Tamir</given-names></name><name><surname>Eisenberg</surname><given-names>David S</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007625</institution-id><institution>Cure Alzheimer's Fund</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Philipp</surname><given-names>Stephan</given-names></name><name><surname>Sosna</surname><given-names>Justyna</given-names></name><name><surname>Glabe</surname><given-names>Charles G</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R56 AG061847</award-id><principal-award-recipient><name><surname>Seidler</surname><given-names>Paul</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>David S Eisenberg, is a SAB member and equity holder in ADRx, Inc.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Diffraction data have been deposited in PDB under the accession code 6O4JSource Data for Toxicity and Seeding data are provided (Figures 2-7)</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Griner SL</collab><collab>Sawaya MR</collab><collab>Rodriguez JA</collab><collab>Cascio D</collab><collab>Gonen T</collab></person-group><year iso-8601-date="2019">2019</year><source>Amyloid Beta KLVFFAENVGS 16-26 D23N Iowa mutation</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/6O4J">https://www.rcsb.org/structure/6O4J</ext-link><comment>Protein Data Bank, 6O4J</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-46924-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>